Molecules / Ambrisentan / China

Ambrisentan API manufacturers in China

CAS 177036-94-1 ATC C02KX02 Updated 9 July 2026
6
China-based manufacturers with an active filing of 8 worldwide
Showing 3 of 6 China-based manufacturers This list is ranked on evidence. Placement cannot be purchased.

Ranked China-based API manufacturers

01

Tianjin Weijie Pharmaceutical

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for ambrisentan, filing since 2016. Its 2024 FDA inspection closed as VAI.

US DMF
1 active
CEP
None on file
Last FDA inspection
2024 · VAI
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
03

Zhejiang Huahai Pharmaceutical

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for ambrisentan, filing since 2013. Its 2025 FDA inspection closed as OAI, and its GMP is recognised in 1 market.

US DMF
1 active
CEP
None on file
Last FDA inspection
2025 · OAI
GMP recognised in
1 markets
How this listing is sourced FDA, List of Drug Master Files
View profile

3 more manufacturers in China hold filings for ambrisentan

The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.

Tianjin Weijie PharmaceuticalJiangsu Joyglory PharmaceuticalZhejiang Huahai Pharmaceutical
Open the full list with a free account

How this list is built

This page filters the worldwide Ambrisentan manufacturer list to companies based in China. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.

Map ambrisentan for your markets

Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.

Start for free
No sales call.

All Ambrisentan manufacturers

Worldwide 8 India 5